| Name | Thesis Advisor | Research Interest | Graduated |
|---|
| Kilsia Mercedes | Catherine Musselman, PhD | My
research interests include protein structure and dynamics, specifically those
involved in inflammatory processes. | 2023 |
| Ruben Rosas Ospina | Mair Churchill, PhD | Molecular
recognition of DNA by chromatin assembly factor 1 | 2023 |
| Lauren Schmitt | Kirk Hansen, PhD | Lauren's
work in the Hansen Lab focuses on characterizing the structure of blood clots
through the identification of FXIIIa cross-links. Our method utilizing
cross-linking mass spectrometry (CL-MS), will allow for the rapid
identification of these cross-links and improve our understanding of the
structure of a blood clot | 2023 |
| Conner Langeberg | Jeffery Kieft, PhD | RNAs
form diverse and complex tertiary structures which relate to their function in
cells where many RNA interacting proteins recognizing these folds. My interests
relate to these protein-RNA interactions in the context of highly structured
non-coding RNAs. | 2023 |
| Eli Martz | Aaron Johnson, PhD | I
am primarily interested in studying chromatin structure. | 2023 |
| Rachel Culp-Hill | Angelo D'Alessandro, PhD | Conventional
chemotherapy for acute myeloid leukemia eliminates most proliferating bulk
tumor cells, but some of the leukemia stem cell population remains. These
remaining cells can lead to disease progression and relapse; targeting them
would result in better outcomes or even curative therapy for AML patients.
Currently, I am working to characterize the aberrant fatty acid metabolism in
leukemic stem cells using metabolomics and mass spectrometry, but my research
also focuses on characterizing metabolic perturbations in leukemia, how altered
pathways contribute to their phenotype, and how they can be targeted for
therapeutic use. | 2022 |
| Maxwell McCabe | Kirk Hansen, PhD | I
am interested in using proteomics to characterize the composition and
architecture of the extracellular matrix (ECM) across different organs with a
focus on would healing. I am currently working to compose an organ-specific ECM
Atlas, characterize the mechanisms of scarless wound-healing in Acomys
cahirinus, and determine pro-regenerative components of decellularized ECM
scaffolds. In the future, I hope to use this information to improve the
rational design of ECM scaffolds for use in regenerative medicine. | 2022 |
| Sara Espinosa | Rui Zhao, PhD | My
research interest is understanding the molecular mechanism of pre-mRNA splicing
and gene expression using biochemical, genetic, and structural approaches | 2022 |
| Cassandra Smith | David Jones, PhD | Structural
analysis of the regulation of mitochondrial trafficking in metastasis | 2022 |
| Natalie Young | Francisco Asturias, PhD | Molecular electron microscopy analysis of mouse mediator | 2021 |
| Alexis Catala | Angelo D'Alessandro, PhD | Biotechnological reprogramming of viruses into therapeutic agents & investigations into dynamic multiparametric metabolic responses of living systems remodeled by pathophysiologic stimuli and/or genetic modifications. | 2021 |
| Alexandra Born | Beat Vogeli, PhD | Allosteric and dynamic relationships driving the mitotic regulator Pin 1 | 2021 |
| Joshua Abbott | Daniel LaBarbara, PhD | Structure-based drug design targeting transcription factors that regulate epithelial to mesenchymal transition. | 2020 |
Schuyler Lee
| Gongyi Zhang, PhD
| Role of JMJD5 and JMJD6 in regulating transcriptional pausing
| 2019 |
Stephen Pollard
| David Pollock, PhD
| Biophysics, protein evolution mechanisms and modeling.
| 2019 |
Vishantie Dostal
| Mair Churchill, PhD | Mitochondrial transcription.
| 2018 |
Erik Hartwick
| Jeffrey Kieft, PhD
| Understanding the structural basis of RNA manipulation of ribosomes by IRES RNAs
| 2018 |
Alexander Barrett
| Kirk Hansen, PhD
| My research interests involve studying tissue remodeling associated with metastatic and non-metastatic tumors and how these changes are reflected in the composition of the extracellular matrix.
| 2017 |
Travis Nemkov
| Kirk Hansen, PhD
| Suffocating the oxygen carriers: Implications for physiology and transfusion medicine
| 2017 |
Ryan Hill
| Kirk Hansen, PhD
| Advances in Extracellular Matrix Proteomics: Applications towards Regenerative Medicine and Disease
| 2016 |
Michael Holliday
| Elan Eisenmesser, PhD
| Determination of the Full Catalytic Cycle among Multiple Cyclophilin Family Members and Limitations on the Application of CPMG-RD in Reversible Catalytic Systems
| 2016 |
Agnieszka (Aga) Kendrick
| Elan Eisenmesser, PhD
| CD147 reprograms pancreatic cancer metabolism via its interaction with small molecule transporters
| 2016 |
Ryan Walsh
| Mark Duncan, PhD
| Quantitative Analysis of Human Tear Fluid
| 2016 |
Melanie Blevins
| Rui Zhao, PhD
| Recipient of the University of Colorado Cancer Center Paul Sandoval Pancreatic Cancer Research Scholarship, "Targeting the Six1-Eya Interaction for Pancreatic Cancer Therapeutics" Targeting protein-protein interactions for potential anti-cancer
therapeutics.
| 2015 |
Candice Wike
| Jessica Tyler, PhD
| Functional Analysis of Phosphorylation of Histone H3 on Threonine 118
| 2014 |
Ying-Chih Chi
| Changwei Liu, PhD
| Understanding of the Structural and Functional Effect of H50Q alpha-synuclein
| 2014 |
Jacek Klepacki
| Uwe Christians, PhD
| Kidney Disfunction Biomarkers for the early Detection of Allograft Injury
| 2014 |
Sten Wie
| Mary Reyland, PhD
| Identifying Non-Receptor Tyrosine Kinases which regulate the pro-apoptotic function of PKC delta
| 2014 |
Aaron Krueger
| Rui Zhao, PhD
| Identification and characterization of specific inhbitors of Eya2 phosphatase
| 2013 |
J. Paul Kirwan
| Robert Hodges, PhD
| A Stability Control Region in Tropomyosin Transmits Long-Range Effects to Provide Optimum Stability
| 2012 |
Jennifer Schlegel
| Douglas Graham, PhD
| Cellular Receptors in Cancer: CD147 and Mer
| 2012 |
